Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
87678921 |
LAW OFFICE ASSIGNED |
LAW OFFICE 120 |
MARK SECTION |
MARK |
Design only |
STANDARD CHARACTERS |
NO |
USPTO-GENERATED IMAGE |
NO |
OWNER SECTION (current) |
NAME |
Ionis Pharmaceuticals, Inc. |
STREET |
2855 Gazelle Court |
CITY |
Carlsbad |
STATE |
California |
ZIP/POSTAL CODE |
92010 |
COUNTRY |
United States |
OWNER SECTION (proposed) |
NAME |
Ionis Pharmaceuticals, Inc. |
STREET |
2855 Gazelle Court |
CITY |
Carlsbad |
STATE |
California |
ZIP/POSTAL CODE |
92010 |
COUNTRY |
United States |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and
conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves,
tissue, organs, intestinal tract, or bone marrow; pharmaceutical preparations and human therapeutic preparations, namely, injectable antisense drugs for reducing production of transthyretin |
GOODS OR SERVICES |
KEEP ALL LISTED |
REQUEST TO DIVIDE |
YES |
EXTENSION SECTION |
EXTENSION NUMBER |
2 |
ONGOING EFFORT |
The applicant believes that it has made valid use of the mark in commerce, and is concurrently filing a Statement of Use (SOU). If the USPTO
finds the SOU to be fatally defective, the applicant will need additional time to file a new SOU. |
ALLOWANCE MAIL DATE |
04/17/2018 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Clifford E Ford/ |
SIGNATORY'S NAME |
Clifford E. Ford |
SIGNATORY'S POSITION |
Vice President, Patents and Senior Patent Counsel |
DATE SIGNED |
03/22/2019 |
SIGNATORY'S PHONE NUMBER |
N/A |
FILING INFORMATION |
SUBMIT DATE |
Sun Mar 24 11:17:31 EDT 2019 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XXX.XX-
20190324111731704142-8767
8921-62048d2edb0657f726e2
9c8c8a903b16e0ec21b41b8b1
c172b9968e5d541fe309-DA-1
1199-20190315123907007621 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: Design only
SERIAL NUMBER: 87678921
The applicant, Ionis Pharmaceuticals, Inc., having an address of
2855 Gazelle Court
Carlsbad, California 92010
United States
XXXX (authorized)
requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 04/17/2018.
For International Class 005:
Current identification: Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases,
disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or
bone marrow; pharmaceutical preparations and human therapeutic preparations, namely, injectable antisense drugs for reducing production of transthyretin
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
The applicant has submitted a Request to Divide in paper or is filing a Request to Divide as part of the TEAS Allegation of Use form. This is the second extension request. The applicant has made the
following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: The applicant believes that it has made valid use of the
mark in commerce, and is concurrently filing a Statement of Use (SOU). If the USPTO finds the SOU to be fatally defective, the applicant will need additional time to file a new SOU.
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Clifford E Ford/ Date Signed: 03/22/2019
Signatory's Name: Clifford E. Ford
Signatory's Position: Vice President, Patents and Senior Patent Counsel
Signatory's Phone: N/A
RAM Sale Number: 87678921
RAM Accounting Date: 03/25/2019
Serial Number: 87678921
Internet Transmission Date: Sun Mar 24 11:17:31 EDT 2019
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XX-201903241117317
04142-87678921-62048d2edb0657f726e29c8c8
a903b16e0ec21b41b8b1c172b9968e5d541fe309
-DA-11199-20190315123907007621